Table 3—

Distribution of body composition variables and relevant covariates after an average of 70 months by sex and treatment group

VariableGroupQuartile
Mean ± SDP value for treatment group differences
25%50%75%
Women
 Age when assessed (years)INT30.0035.0040.0035.11 ± 6.110.1148
CON30.0034.0039.0034.29 ± 5.99
 Length of follow-up (months)INT60.0069.0083.0072.09 ± 19.950.8220
CON57.0069.0084.0072.15 ± 20.11
 Weight (kg)INT62.0568.9078.9071.79 ± 13.340.0001
CON60.4066.1072.7067.16 ± 9.82
 Height (cm)INT161.00164.90169.00164.80 ± 6.200.2504
CON161.80165.43169.25165.49 ± 5.63
 BMI (kg/m2)INT22.9825.4628.7526.42 ± 4.60<0.0001
CON22.2724.3026.0024.50 ± 3.18
 HbAlc (% of hemoglobin)INT6.67.17.77.2 ± 1.0<0.0001
CON7.99.110.29.1 ± 1.6
 Estimated percent body fatINT28.0232.7036.9132.51 ± 6.080.0002
CON26.7730.6734.3530.68 ± 5.27
 Estimated fat-free mass (kg)INT43.6147.2251.4747.84 ± 5.950.0007
CON42.4645.5448.9646.21 ± 4.92
 Natural WHRINT0.720.760.800.76 ± 0.080.7292
CON0.720.750.790.76 ± 0.05
 Waist circumference (cm)INT71.9577.0584.6579.03 ± 9.970.0004
CON70.8575.0579.7075.75 ± 7.25
Men
 Age when assessed (years)INT31.0035.0040.0035.23 ± 5.560.8618
CON31.0035.0039.0035.17 ± 5.44
 Length of follow-up (months)INT58.0069.0083.0070.95 ± 19.690.6647
CON57.0066.0083.0070.31 ± 18.94
 Weight (kg)INT74.5582.0390.4083.52 ± 12.84<0.0001
CON73.0581.1088.2081.60 ± 11.29
 Height (cm)INT173.80178.00182.40178.41 ± 6.600.1693
CON174.40178.70184.00179.02 ± 7.23
 BMI (kg/m2)INT23.8625.7228.1426.20 ± 3.46<0.0001
CON23.6525.1627.3125.43 ± 2.92
 HbA1c (% of hemoglobin)INT6.67.17.67.2 ± 1.0<0.0001
CON8.49.210.09.2 ± 1.3
 Estimated percent body fatINT16.0719.7923.8919.79 ± 6.130.0557
CON14.8618.4623.2618.92 ± 5.83
 Estimated fat-free mass (kg)INT60.7465.9471.3066.53 ± 8.100.3397
CON60.2864.9070.9065.84 ± 7.86
 Natural WHRINT0.830.870.910.87 ± 0.070.8103
CON0.840.870.900.87 ± 0.06
 Waist circumference (cm)INT81.6586.6094.2588.51 ± 9.820.1028
CON81.0086.0091.7086.99 ± 8.13
  • P values are from the Wilcoxon’s rank-sum test. BMI was tested after adjustment for covariance with baseline BMI. Weight, percent body fat, and fat-free mass were all adjusted for covariance with weight at baseline. INT, intensive therapy (n = 298); CON, conventional therapy (n = 337).